Stay updated on Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Footer version badge updated from v3.6.0 to v3.6.2, indicating an upgrade to the site's interface/version. This change does not alter study data, eligibility, or results on the page.
    Difference
    0.0%
    Check dated 2026-06-27T23:20:15.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Recruitment status updated to no longer look for participants, indicating enrollment has closed. The page history now lists revision v3.6.0 and removes the prior revision v3.5.5.
    Difference
    0.2%
    Check dated 2026-06-13T16:52:37.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The site footer now shows Revision: v3.5.5, replacing the previous v3.5.4, signaling a new platform release. This update does not modify study records or visible page content.
    Difference
    0.0%
    Check dated 2026-06-06T12:25:43.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    A new revision v3.5.4 was added to the study record history, superseding the previous v3.5.3. This update records the latest page changes.
    Difference
    0.0%
    Check dated 2026-05-15T02:17:06.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page's revision history now lists Revision: v3.5.3. The previous entry Revision: v3.5.2 is removed from the history listing.
    Difference
    0.0%
    Check dated 2026-04-30T18:57:48.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2 in the page metadata (footer), a technical version change with no impact on study content.
    Difference
    0.0%
    Check dated 2026-04-16T11:15:56.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial page.